Additive effects of nicorandil on coronary blood flow during continuous administration of nitroglycerin.

[1]  Y. Taniyama,et al.  Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. , 1999, Journal of the American College of Cardiology.

[2]  S. Ogawa,et al.  Differential effects of N-acetylcysteine on nitroglycerin- and nicorandil-induced vasodilation in human coronary circulation. , 1998, Journal of cardiovascular pharmacology.

[3]  S. Ogawa,et al.  Nicorandil Augments Regional Ischemia‐Induced Monophasic Action Potential Shortening and Potassium Accumulation without Serious Proarrhythmia , 1995, Journal of cardiovascular pharmacology.

[4]  Raymond C. Schneider,et al.  ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction , 1995, The Lancet.

[5]  E. Fallen,et al.  Redistribution of myocardial blood flow with topical nitroglycerin in patients with coronary artery disease. , 1995, Circulation.

[6]  M. Sekiguchi,et al.  Coronary microvascular response to intracoronary administration of nicorandil. , 1995, The American journal of cardiology.

[7]  K. Kato.  Haemodynamic and clinical effects of an intravenous potassium channel opener--a review. , 1993, European heart journal.

[8]  H. Suryapranata.  Coronary haemodynamics and vasodilatory profile of a potassium channel opener in patients with coronary artery disease. , 1993, European heart journal.

[9]  Kaushik D. Meisheri,et al.  Nicorandil‐Induced Vasorelaxation: Functional Evidence for K+ Channel‐Dependent and Cyclic GMP‐Dependent Components in a Single Vascular Preparation , 1991, Journal of cardiovascular pharmacology.

[10]  G. Pöch,et al.  Dual Mechanism of the Relaxing Effect of Nicorandil by Stimulation of Cyclic GMP Formation and by Hyperpolarization , 1991, Journal of cardiovascular pharmacology.

[11]  T. Aizawa,et al.  Effect of nicorandil on coronary spasm. , 1989, The American journal of cardiology.

[12]  M. Nakamura,et al.  Effects of nicorandil on rest and effort angina unresponsive to combination therapy with a calcium antagonist and oral nitrate. , 1987, Clinical therapeutics.

[13]  R. O'rourke,et al.  Alterations in regional myocardial blood flow after nitroprusside and nitroglycerin in patients with and without significant coronary artery disease. , 1986, The American journal of cardiology.

[14]  B. Rosner,et al.  Nifedipine and conventional therapy for unstable angina pectoris: a randomized, double-blind comparison. , 1984, Circulation.

[15]  F. Yin,et al.  Regional coronary blood flow during relief of pacing-induced angina by nitroglycerin. Implications for mechanism of action. , 1983, The American journal of cardiology.

[16]  Y. Imai,et al.  PHARMACOLOGICAL PROFILE OF A NEW CORONARY VASODILATOR DRUG, 2‐NICOTINAMIDOETHYL NITRATE (SG‐75) , 1979, Clinical and experimental pharmacology & physiology.